Meeting
2016 Gastrointestinal Cancers Symposium
Prognostic significance of programmed death-ligand 1 (PD-L1) expression on tumor infiltrating immune cells (IC) in patients with stage IIIb colorectal cancer.
Authors
Shigehiro Koganemaru
Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan
Shigehiro Koganemaru , Naoko Inoshita , Yuji Miura , Yudai Fukui , Yukinori Ozaki , Kenji Tomizawa , Yutaka Hanaoka , Shigeo Toda , Koichi Suyama , Yuko Tanabe , Jin Moriyama , Takeshi Fujii , Shuichiro Matoba , Hiroya Kuroyanagi , Toshimi Takano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 611)
DOI
10.1200/jco.2016.34.4_suppl.611
Abstract #
611
Poster Bd #
F16
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Analysis of disease-free survival in CheckMate 274 by PD-L1 combined positive score and tumor proportion score.
First Author: Matt D. Galsky
Poster
2021 ASCO Annual Meeting
PD-L1 expression and TOP3A mutation as prognostic factors for adjuvant chemotherapy in triple negative breast cancer.
First Author: Xue Wang
Poster
2023 ASCO Annual Meeting
A comprehensive pan-cancer analysis of PD-L1 expression using clone E1L3N in Chinese patients with cancer.
First Author: Huangbin Lu
Poster
2023 ASCO Annual Meeting
Differential benefit of capecitabine-based chemotherapy among TNBC subtypes in the context of the CBCSG010 study.
First Author: Junjie Li